Spektus Pharma and GEBRO Partner to Commercialise Extended-Release Pain Management Drug
Spektus Pharma and GEBRO Holding enter into a global commercialisation partnership for ActraFlex, a twice-daily extended-release formulation of tramadol and paracetamol for pain management.
GEBRO Holding GmbH | 12/11/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy